|
UGCG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.741500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.904100E-02 |
| Normal-vs-Stage2 |
1.356030E-03 |
| Normal-vs-Stage3 |
6.812100E-02 |
| Normal-vs-Stage4 |
5.406400E-02 |
| Stage1-vs-Stage2 |
2.113600E-02 |
| Stage1-vs-Stage3 |
6.438800E-01 |
| Stage1-vs-Stage4 |
5.021200E-01 |
| Stage2-vs-Stage3 |
6.226400E-02 |
| Stage2-vs-Stage4 |
1.245030E-01 |
| Stage3-vs-Stage4 |
7.644600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.154990E-01 |
| Normal-vs-AfricanAmerican |
2.787000E-01 |
| Normal-vs-Asian |
6.514000E-02 |
| Caucasian-vs-AfricanAmerican |
8.984000E-01 |
| Caucasian-vs-Asian |
4.597600E-01 |
| AfricanAmerican-vs-Asian |
6.894600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.688490E-02 |
| Normal-vs-Female |
4.936300E-02 |
| Male-vs-Female |
1.928770E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.998800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.861600E-03 |
| Normal-vs-Age(61-80Yrs) |
4.044500E-03 |
| Normal-vs-Age(81-100Yrs) |
7.104200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.323900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.040480E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.974400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.199000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.135800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.995000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.979800E-01 |
| Classical-VS-Follicular |
5.85087533977457E-14 |
| Classical-VS-Other |
3.500100E-03 |
| Classical-VS-Normal |
4.169000E-01 |
| Tall-VS-Follicular |
8.047100E-04 |
| Tall-VS-Other |
6.768200E-02 |
| Tall-VS-Normal |
3.244600E-01 |
| Follicular-VS-Other |
9.968400E-01 |
| Follicular-VS-Normal |
4.50000000040696E-07 |
| Other-VS-Normal |
1.302630E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.421140E-03 |
| Normal-vs-N1 |
9.098300E-02 |
| N0-vs-N1 |
1.763440E-01 |
|
|
